Researchers uncover first breakthrough in Mayr therapy in Africa

A team of researchers from Nigeria have discovered how Mayr type of detoxification may positively affect fertility indices in infertile couples who undergo assisted reproductive technology.

The researchers in their study titled, ‘Managing environmental exposure in clinical practice,’ and published in the journal, Global Reproductive Health, noted that environmental toxins from various occupational industries, such as oil and gas, petrochemical, agriculture and bad eating habits could cause serious health hazards.

This study described the clinical success of Modern Mayr therapy type of detoxification in a fertility practice that uses detoxification as a complementary treatment. The researchers, led by Prof. Oladapo Ashiru, engaged a total of 218 infertile patients undergoing in-vitro fertilisation treatment from January 2014 to December 2017 at the Medical Art Center in Lagos.

The infertile patients were referred to MART-Life Detox clinic for a supervised modern Mayr-type of detoxification before further assisted reproductive technology treatment.

“The patients were placed in two groups –  Group A consisted of 131 patients with a history of one or more failed IVF cycles at MART before commencing Mayr therapy. Group B consisted of 87 patients with no previous IVF treatment at MART.

“Mayr therapy using special dietary nutrition and equipment such as hypoxicator and sea oxygenator was performed. Improvement in their fertility outcomes with regards to oocyte yield, pregnancy and live birth rate were assessed in subsequent cycles following detoxification,” Ashiru said.

He added that 89 per cent of all patients achieved significant weight reduction and improvement in body mass index after undergoing Mayr therapy.

“Uniform increase in oocyte yield was observed but this was particularly noticeable in previous poor responders in group A. Records showed positive hCG rates of 41.2 per cent and 30 per cent, clinical pregnancy rates of 27.5 per cent and 21.8 per cent, and live birth rates of 23.7 per cent and 15 per cent, in group A and B, respectively. There are currently five ongoing pregnancies in group A and six in group B,” Ashiru said.

The researchers, however, said there was a need for randomised and controlled trials in larger populations to establish a pattern of response.

Add Your Comment: